These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16529563)

  • 21. Pharmacotherapy for stress urinary incontinence.
    Castro-Diaz D; Amoros MA
    Curr Opin Urol; 2005 Jul; 15(4):227-30. PubMed ID: 15928510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duloxetine in women awaiting surgery.
    Drutz H
    BJOG; 2006 May; 113 Suppl 1():17-21. PubMed ID: 16529565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.
    Millard RJ; Moore K; Rencken R; Yalcin I; Bump RC;
    BJU Int; 2004 Feb; 93(3):311-8. PubMed ID: 14764128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of duloxetine on urethral function and sphincter morphology.
    Athanasiou S; Chaliha C; Digesu GA; Sotiropoulou M; Georgoulias N; Khullar V; Antsaklis A
    Int Urogynecol J Pelvic Floor Dysfunct; 2007 Jul; 18(7):763-7. PubMed ID: 17061027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurobiology of stress urinary incontinence: new insights and implications for treatment.
    Cardozo L
    J Obstet Gynaecol; 2005 Aug; 25(6):539-43. PubMed ID: 16234136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat.
    Thor KB; Katofiasc MA
    J Pharmacol Exp Ther; 1995 Aug; 274(2):1014-24. PubMed ID: 7636716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Duloxetine on Urethral Resting Pressure and on Sphincter Contractility in Response to Coughing and Magnetic Stimulation in Healthy Women.
    Yono M; Otani M; Ito K; Inoue Y; Furukawa K; Hori M; Tsuji S; Tanaka T; Sakata Y; Irie S
    Low Urin Tract Symptoms; 2015 May; 7(2):93-8. PubMed ID: 26663688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
    Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
    Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress urinary incontinence in women: review and update on neurological control.
    Miller KL
    J Womens Health (Larchmt); 2005 Sep; 14(7):595-608. PubMed ID: 16181016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological treatment of women awaiting surgery for stress urinary incontinence.
    Cardozo L; Drutz HP; Baygani SK; Bump RC
    Obstet Gynecol; 2004 Sep; 104(3):511-9. PubMed ID: 15339761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter.
    Troelsen KB; Nielsen EØ; Mirza NR
    Psychopharmacology (Berl); 2005 Oct; 181(4):741-50. PubMed ID: 16032412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha2-adrenoceptor blockade potentiates the effect of duloxetine on sneeze induced urethral continence reflex in rats.
    Kitta T; Miyazato M; Chancellor MB; de Groat WC; Nonomura K; Yoshimura N
    J Urol; 2010 Aug; 184(2):762-8. PubMed ID: 20639053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duloxetine for management of stress urinary incontinence.
    Guay DR
    Am J Geriatr Pharmacother; 2005 Mar; 3(1):25-38. PubMed ID: 16089245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New options in pharmacological treatment of urinary stress incontinence in women].
    Martan A
    Ceska Gynekol; 2004 Nov; 69(6):500-6. PubMed ID: 15633423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial management of stress urinary incontinence: pelvic floor muscle training and duloxetine.
    Freeman RM
    BJOG; 2006 May; 113 Suppl 1():10-6. PubMed ID: 16529564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Duloxetine on Urethral Continence Reflex and Bladder Activity in Rats with Cerebral Infarction.
    Miyazato M; Kitta T; Kaiho Y; Oshiro T; Saito S; Chancellor MB; de Groat WC; Yoshimura N
    J Urol; 2015 Sep; 194(3):842-7. PubMed ID: 25804088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Duloxetine and other tricyclic antidepressive agents: pharmacodynamic effects in the lower urinary tract].
    Vela Navarrete R; Pérez Martínez FC; Ramírez Pérez del Yerro M; Cabrera Pérez J; González Enguita C
    Actas Urol Esp; 2004 Mar; 28(3):252. PubMed ID: 15141426
    [No Abstract]   [Full Text] [Related]  

  • 38. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
    Westanmo AD; Gayken J; Haight R
    Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and tolerability of duloxetine in women with stress urinary incontinence.
    Oelke M; Roovers JP; Michel MC
    BJOG; 2006 May; 113 Suppl 1():22-6. PubMed ID: 16529566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of Duloxetine in the treatment of male stress urinary incontinence.
    Fink KG; Huber J; Würnschimmel E; Schmeller NT
    Wien Med Wochenschr; 2008; 158(3-4):116-8. PubMed ID: 18330528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.